In our BC cohort, NLRP3 and PYCARD expression was higher in the tumor samples than in the non-cancerous counterparts, thus confirming inflammasome involvement in establishing a tumor-associated microenvironment to support cancer progression (26). The gene discussed is NLRP3; the disease is neoplasm.